產品描述: | BVT948 is a protein tyrosine phosphatase (PTP) inhibitor which can also inhibit several cytochrome P450 (P450) isoforms and lysine methyltransferase SETD8 (KMT5A). |
靶點: |
PTP, P450, SETD8;Phosphatase;P450;HistoneMethyltransferase |
體內研究: |
Results show that 3 μmol/kg BVT948 (BVT.948) significantly enhances glucose clearance from the blood stream in response to insulin compare with vehicle-treated controls |
參考文獻: |
1. Liljebris C, et al. Oxidation of protein tyrosine phosphatases as a pharmaceutical mechanism of action: a study using 4-hydroxy-3,3-dimethyl-2H-benzo[g]indole-2,5(3H)-dione. J Pharmacol Exp Ther. 2004 May;309(2):711-9. 2. Blum G, et al. Small-molecule inhibitors of SETD8 with cellular activity. ACS Chem Biol. 2014 Nov 21;9(11):2471-8. 3. Hwang BM, et al. Protein tyrosine phosphatase controls breast cancer invasion through the expression of matrix metalloproteinase-9. BMB Rep. 2013 Nov;46(11):533-8. |
溶解性: |
Soluble in DMSO |
保存條件: |
-20°C |
配置溶液濃度參考: |
|
1mg |
5mg |
10mg |
1 mM |
4.145 ml |
20.726 ml |
41.452 ml |
5 mM |
0.829 ml |
4.145 ml |
8.29 ml |
10 mM |
0.415 ml |
2.073 ml |
4.145 ml |
50 mM |
0.083 ml |
0.415 ml |
0.829 ml |
|
注意: |
部分產品我司僅能提供部分信息,我司不保證所提供信息的權威性,僅供客戶參考交流研究之用。 |